Assessment of Androgen Receptor Splice Variant-7 as a Biomarker of Clinical Response in Castration-Sensitive Prostate Cancer. (2022)
Attributed to:
BAG-1: A novel strategy for targeting the androgen receptor splice variants in castrate resistant prostate cancer.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1158/1078-0432.ccr-22-0851
PubMed Identifier: 35695870
Publication URI: http://europepmc.org/abstract/MED/35695870
Type: Journal Article/Review
Volume: 28
Parent Publication: Clinical cancer research : an official journal of the American Association for Cancer Research
Issue: 16
ISSN: 1078-0432